This bid is closed — responses were due May 7, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This grant opportunity, PAR-25-111, focuses on translational research in maternal and pediatric pharmacology and therapeutics. It is an R21 Clinical Trial Optional grant, and funding is available through CFDA numbers 93.865, 93.855, 93.279, and 93.313.
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.